Chris Storgard Net Worth & Insider Trades
Chris Storgard - Chief Medical Officer, Fate Therapeutics Inc
What is Chris Storgard's Net Worth?
The current estimated net worth of Fate Therapeutics Inc's Chief Medical Officer, Chris Storgard, is estimated to be about $92.04K . Chris Storgard owns about 46,683 units of Fate Therapeutics Inc common stock. In the last 2 years at Fate Therapeutics Inc, Chris Storgard has sold an estimated value of $0 worth.
What is Chris Storgard's Past Insider Trading?
Chris Storgard's largest purchase order was 37,593 units , worth over $100K on November 28, 2016. In total, Chris Storgard has made about 4 transactions over 2 years of their time at Fate Therapeutics Inc. Chris Storgard usually trades in January, with the busiest year in 2016.
Chris Storgard
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Chris Storgard's' Mailing Address?
- Mailing address is C/o Fate Therapeutics, Inc. 3535 General Atomics Court, Ste 200 San Diego CA 92121 CA
Fate Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| J. Scott Wolchko | 2020 | $570,000 | - | $1,451,340 | $3,222,577 | $356,250 | - | $5,600,167 |
| J. Scott Wolchko | 2019 | $540,000 | - | $4,137,500 | $5,732,955 | $310,500 | - | $10,720,955 |
| J. Scott Wolchko | 2018 | $516,000 | - | - | $2,756,998 | $258,000 | - | $3,530,998 |
| Edward J. Dulac III | 2020 | $142,500 | $137,917 | $1,420,800 | $3,786,529 | $75,833 | $120,000 | $5,683,579 |
| Bahram Valamehr, Ph.D. | 2020 | $390,000 | - | $549,750 | $1,324,347 | $195,000 | - | $2,459,097 |
| Bahram Valamehr, Ph.D. | 2019 | $375,000 | - | $744,750 | $1,547,898 | $150,938 | - | $2,818,586 |
| Bahram Valamehr, Ph.D. | 2018 | $321,865 | - | - | $2,138,235 | $117,250 | - | $2,577,350 |
| Cindy R. Tahl, J.D. | 2020 | $390,000 | - | $549,750 | $1,324,347 | $195,000 | - | $2,459,097 |
| Cindy R. Tahl, J.D. | 2019 | $375,000 | - | $744,750 | $1,547,898 | $150,938 | - | $2,818,586 |
| Cindy R. Tahl, J.D. | 2018 | $350,000 | - | - | $906,465 | $122,500 | - | $1,378,965 |
| Daniel D. Shoemaker, Ph.D. | 2020 | $390,000 | - | $549,750 | $1,324,347 | $195,000 | - | $2,459,097 |
| Daniel D. Shoemaker, Ph.D. | 2019 | $375,000 | - | $744,750 | $1,547,898 | $150,938 | - | $2,818,586 |
| Daniel D. Shoemaker, Ph.D. | 2018 | $365,000 | - | - | $842,338 | $127,750 | - | $1,335,088 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1434316/000119312521124699/d85377ddef14a.htm
What are Fate Therapeutics Inc's Past Insider Trades?
Fate Therapeutics Inc's most recent insider trade came on January 13, 2023 by John Mendlein who bought 124,679 units worth $698.14K . In the last 10 years, insiders at Fate Therapeutics Inc have sold an estimated value of $126.99M and bought an estimated value of $171.64M worth of shares. Insider trading is most common in January, with the busiest year in 2021. The most active traders at the company are Scott Wolchko, President and CEO, Cindy Tahl, General Counsel and Secretary, and Amir Nashat, Director .
FATE THERAPEUTICS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||